Hu Shaomin, Szymanski James, Khairy Zeina, Lo Yungtai, Wang Yanhua
Department of Pathology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, United States.
Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, United States.
Ann Diagn Pathol. 2018 Aug;35:11-15. doi: 10.1016/j.anndiagpath.2018.02.002. Epub 2018 Feb 11.
Although recent technological advances, there is still discordance between mammography findings and pathologic diagnoses, especially for certain racial/ethnic populations. In this study we correlated the mammography BI-RADS categories with pathologic diagnoses, aiming to evaluate the performance of mammography in breast cancer detection in a unique poor population consisting of mostly Hispanics and African Americans. A total of 3935 female patients with a breast mammography and a subsequent breast pathology report within 90 days were retrospectively analyzed. There were 875 (22.2%) patients with a negative or probably benign mammography (BI-RADS 1, 2 and 3), and 33 (3.8%) of them had a malignant pathologic diagnosis. Patients with malignant pathologic diagnoses were older, higher in socioeconomic status (SES), and more likely to be African American or White, compared to those with non-malignant pathologic findings. They mostly presented with related symptoms (e.g. breast pain, mass or discharge) and/or family history or past history of breast cancers, which triggered secondary imaging examination and subsequent breast biopsy/excision, and eventually resulted to the diagnosis of breast cancers. In conclusion, our studies indicated that the performance of mammography is comparable in detection of breast cancers among Hispanics, African American and White populations, if it was done in the same facility. Our results also suggested that for patients with presenting symptoms, past history of breast cancer or strong family history of breast cancer, a secondary breast imaging examination may be warranted following a negative to probably benign mammography (BI-RADS 1-3).
尽管近年来技术有所进步,但乳腺钼靶检查结果与病理诊断之间仍存在不一致性,尤其是在某些种族/族裔人群中。在本研究中,我们将乳腺钼靶BI-RADS分类与病理诊断相关联,旨在评估乳腺钼靶在一个主要由西班牙裔和非裔美国人组成的独特贫困人群中检测乳腺癌的性能。对90天内进行乳腺钼靶检查并随后有乳腺病理报告的3935名女性患者进行了回顾性分析。有875名(22.2%)患者的乳腺钼靶检查结果为阴性或可能为良性(BI-RADS 1、2和3),其中33名(3.8%)有恶性病理诊断。与非恶性病理结果的患者相比,恶性病理诊断的患者年龄更大,社会经济地位(SES)更高,更可能是非裔美国人或白人。他们大多表现出相关症状(如乳房疼痛、肿块或溢液)和/或乳腺癌家族史或既往史,这促使他们进行二次影像学检查及随后的乳腺活检/切除,最终确诊为乳腺癌。总之,我们的研究表明,如果在同一机构进行乳腺钼靶检查,其在西班牙裔、非裔美国人和白人人群中检测乳腺癌的性能相当。我们的结果还表明,对于有症状、乳腺癌既往史或乳腺癌家族史强烈的患者,在乳腺钼靶检查结果为阴性或可能为良性(BI-RADS 1-3)后,可能需要进行二次乳腺影像学检查。